Literature DB >> 10978902

PML and the oncogenic nuclear domains in regulating transcriptional repression.

H Li1, J D Chen.   

Abstract

Promyelocytic leukemia protein (PML) is a tumor suppressor involved in the t(15;17) translocation that causes acute promyelocytic leukemia (APL). PML is located at multiple nuclear domains known as PML oncogenic domains (PODs), whose structures are dynamically regulated and disrupted in t(15;17) APL cells. PML is involved in several important cellular processes; however, its exact function is unclear. Recently, a POD-associated protein was found to be transcriptional repressor, suggesting a new role for PODs in regulating transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978902     DOI: 10.1016/s0955-0674(00)00144-7

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  3 in total

1.  Signal-dependent regulation of transcription by histone deacetylase 7 involves recruitment to promyelocytic leukemia protein nuclear bodies.

Authors:  Chengzhuo Gao; Xiwen Cheng; Minh Lam; Yu Liu; Qing Liu; Kun-Sang Chang; Hung-Ying Kao
Journal:  Mol Biol Cell       Date:  2008-05-07       Impact factor: 4.138

2.  Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells.

Authors:  Hye-Ra Lee; Do-Jun Kim; Jang-Mi Lee; Cheol Yong Choi; Byung-Yoon Ahn; Gary S Hayward; Jin-Hyun Ahn
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Real-time transcriptional profiling of cellular and viral gene expression during lytic cytomegalovirus infection.

Authors:  Lisa Marcinowski; Michael Lidschreiber; Lukas Windhager; Martina Rieder; Jens B Bosse; Bernd Rädle; Thomas Bonfert; Ildiko Györy; Miranda de Graaf; Olivia Prazeres da Costa; Philip Rosenstiel; Caroline C Friedel; Ralf Zimmer; Zsolt Ruzsics; Lars Dölken
Journal:  PLoS Pathog       Date:  2012-09-06       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.